0000000000414423

AUTHOR

Nicasio Ventura

0000-0001-9842-3930

showing 2 related works from this author

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Bi…

2020

Purpose There has been an increasing clinical interest in specific retinal parameters as non-invasive biomarkers of retinal inflammation in diabetic macular edema (DME) that have been shown to have prognostic value, such as hyperreflective retinal fields (HRFs) and subfoveal neuroretinal detachment (SND). Methods We conducted a prospective, non-comparative study of treatment-naive patients with DME to evaluate the efficacy of a Pro Re Nata (PRN) regimen of intravitreal dexamethasone implant 0.7 mg (DexI, Ozurdex™). After administration, patients underwent subsequent injections according to PRN criteria in case of edema relapse, but not earlier than 4 months after the previous treatment. Pat…

medicine.medical_specialtyreal-worldVisual acuitygenetic structures03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePro re nataDexamethasone implant Diabetic macular edema Inflammation Intravitreal implants Ozurdex Real-worldEdemaOphthalmologymedicinedexamethasone implantAdverse effectDexamethasoneOriginal Researchbusiness.industrySettore MED/30 - Malattie Apparato VisivoRetinaleye diseasesOphthalmologyRegimenintravitreal implantschemistryinflammationOzurdex030221 ophthalmology & optometryImplantsense organsmedicine.symptombusinessdiabetic macular edema030217 neurology & neurosurgerymedicine.drugClinical ophthalmology (Auckland, N.Z.)
researchProduct

The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases.

2020

Purpose: To assess the usefulness of a dedicated questionnaire for patients with inflammatory bowel diseases (IBD) treated with biological drugs for the detection of ocular extraintestinal manifestations (EIMs). IBD can cause extraintestinal symptoms including ocular complaints which are frequently ignored and may be associated with significant morbidity, including blindness. Methods: We developed a questionnaire, named Ocular Manifestations in IBD Screening (OMIS) questionnaire, after agreement between gastroenterologists and ophthalmologists. The questionnaire was administered by a non-ophthalmologist physician to 96 IBD patients treated with biological drugs. Results: 35 patients (36.5%)…

Clinical teammedicine.medical_specialtygenetic structuresScreening testPilot ProjectsInflammatory bowel diseaseBiological drugsQuality of lifeInternal medicineSurveys and QuestionnairesmedicineHumansBlindnessBiologic drugs Inflammatory bowel disease Ocular extraintestinal manifestation QuestionnaireOphthalmologistsbusiness.industrySettore MED/30 - Malattie Apparato VisivoInflammatory Bowel Diseasesmedicine.diseaseInflammatory Bowel Diseasesdigestive system diseaseseye diseasesOphthalmologyOphthalmologic examinationQuality of LifebusinessInternational ophthalmology
researchProduct